Esophageal Mucosal Injuries From Drugs, Radiation, and Caustic Agents
- PMID: 40550544
- PMCID: PMC12173573
- DOI: 10.7704/kjhugr.2025.0023
Esophageal Mucosal Injuries From Drugs, Radiation, and Caustic Agents
Abstract
Various factors can lead to esophageal mucosal injury. A thorough patient history is crucial to accurately diagnose esophageal injuries caused by drugs, radiation, and caustic agents. These conditions are often identifiable based on characteristic clinical features, concomitant diseases, and endoscopic findings and do not necessarily require histological confirmation through biopsies. Regardless of the underlying cause, avoiding or minimizing the offending agent is essential for preventing further mucosal damage. In cases where this is unavoidable, such as radiationinduced esophageal injuries, careful adjustment of the radiation dose, field, and frequency is necessary. Additionally, the use of mucosal protective agents and adherence to a soft diet can help regenerate the mucosal epithelium. Esophageal mucosal injuries can cause chronic complications, such as esophageal strictures; therefore, they require close monitoring. Notably, injuries induced by caustic agents carry an increased risk of progression to esophageal cancer, underscoring the importance of long-term surveillance.
Keywords: Caustics; Chemically-induced disorders; Esophagitis; Gastrointestinal endoscopy; Radiation injuries.
Conflict of interest statement
Younghee Choe, a contributing editor of the
Figures



Similar articles
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
-
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080. Health Technol Assess. 2006. PMID: 16545207
-
Radiation-induced injury and the gut microbiota: insights from a microbial perspective.Therap Adv Gastroenterol. 2025 Jun 16;18:17562848251347347. doi: 10.1177/17562848251347347. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40535532 Free PMC article. Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
References
-
- Graham DY. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci. 2002;47:1665–1678. - PubMed
-
- de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016–1021. - PubMed
-
- Macedo G, Azevedo F, Ribeiro T. Ulcerative esophagitis caused by etidronate. Gastrointest Endosc. 2001;53:250–251. - PubMed
-
- Lanas AI, Sousa FL, Ortego J, et al. Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. Eur J Gastroenterol Hepatol. 1995;7:1065–1072. - PubMed
-
- Katzka DA. In: Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. Vol. 1. 11th ed. Feldman M, Friedman LS, Brandt LJ, editors. Philadelphia: Elsevier; 2020. Esophageal disorders caused by medications, trauma, and infection; pp. 661–664.
Publication types
LinkOut - more resources
Full Text Sources